ea0021cm3.3 | Management of congenital adrenal hyperplasia across the lifespan | SFEBES2009
Ross R J
, Willis D S
, Wild S H
, Krone N
, Doherty E J
, Han T S
, Carroll P V
, Conway G S
, Rees D A
, Stimson R H
, Walker B R
, Connell J C
, Arlt W
Background: No treatment guidelines exist for CAH adults. To address this we have undertaken a cross-sectional analysis of health status.Patients and methods: Three hundred and eighty patients from 17 tertiary centres were contacted: 203 (53%) consented (138 f, 65 m, median age 34 (range 1869) years). One hundred and sixty-five had classic and 34 non-classic CAH. The UK prevalence is 3591 adults >18 years therefore the capture rate was 5.7%. Re...